How can we help?
Hepatitis B Core (anti-HBc), IgM antibody

Hepatitis B Core (anti-HBc), IgM antibody

Also referred as
Anti-HBc IgM
Anti-HBc
For men & women
Earliest reports in
48 hours
Contains
1 test
Know more about this test

The Hepatitis B Core (anti-HBc), IgM antibody is a blood test that detects the presence of IgM antibodies against the hepatitis B core antigen (anti-HBc). It helps determine whether an individual has an acute or recent hepatitis B infection, aiding in early diagnosis and timely intervention to prevent complications.

Samples required
Blood
Find out
Why is this test booked?
Preparations
No special preparation is required.
Sample Collection
Who will collect your samples?

Understanding Hepatitis B Core (anti-HBc), IgM antibody

The hepatitis B (Core) IgM antibody, or anti-HBc IgM, is a specific type of antibody produced by the immune system during the active stage of a hepatitis B virus (HBV) infection. The immune system makes IgM antibodies for the core of HBV several weeks after an individual is infected. These antibodies are typically detectable in the blood during the early stages of acute infection, and their presence indicates that the infection is ongoing. 

It is noteworthy that individuals who have received the hepatitis B vaccine will not have the core antibody (anti-HBc) in their blood because the vaccine doesn’t provide protection in that way.  The detection of anti-HBc IgM is therefore a key marker for distinguishing an acute infection from a past or resolved infection, helping doctors assess whether the infection is recent or chronic. In some cases, it can also help identify individuals who may be in the "window period" of infection, when the hepatitis B surface antigen (HBsAg) may not be detectable but the HBV is still present in the body. Therefore, the test can help assess the timing and activity of the infection, which is crucial for treatment decisions.

The Hepatitis B Core (anti-HBc), IgM antibody is usually recommended to individuals who are showing symptoms of hepatitis B, such as nausea, loss of appetite, muscle aches, fever, jaundice (yellow skin and eyes), dark-colored urine, belly pain, etc. It is also advised for those at higher risk of exposure to the virus, including individuals who have had unprotected sex with someone infected with hepatitis B, live in close contact with an infected person, were born to a mother with the hepatitis B virus (HBV), or work in healthcare settings with potential blood exposure. 

A positive result may indicate that the infection is in its early, active phase and that the individual is potentially contagious. In contrast, a negative result can rule out acute infection and point towards other causes of symptoms or liver dysfunction. In conjunction with other tests, such as the Hepatitis B surface antigen (HBsAg) test and Hepatitis B DNA (viral load) test, the Hepatitis B Core (anti-HBc), IgM antibody test provides a comprehensive picture of an individual's hepatitis B infection status.

No special preparation is needed for this test. Eating and drinking can be done as per the daily routine. However, inform the doctor about all the medications or supplements or underlying liver conditions, as these factors may influence the test results. 

Lab test results may vary across laboratories. Talk to the doctor about the specific test results. Abnormal test results require an expert interpretation. Therefore, never try to self-medicate based solely on these results. Always consult a doctor for a proper understanding of the test results. 

See more

What does Hepatitis B Core (anti-HBc), IgM antibody measure?

The Hepatitis B Core (anti-HBc), IgM antibody test measures the presence of IgM antibodies produced by the immune system in response to the hepatitis B core antigen (anti-HBc). The presence of these antibodies helps differentiate between active and past infections and can identify individuals in the early stages of infection. By detecting anti-HBc IgM, the test provides critical information about the timing of the infection, helping doctors determine whether the infection is acute (recent) or possibly chronic.

Overall, the Hepatitis B Core (anti-HBc), IgM antibody test is a key diagnostic tool in identifying recent hepatitis B infections, guiding treatment decisions, and determining the potential risk for transmission to others. By distinguishing between acute and chronic infection, it allows doctors to closely monitor the infection's progression and decide on the best course of action for preventing complications such as liver damage, cirrhosis, or liver cancer.

FAQs related to Hepatitis B Core (anti-HBc), IgM antibody

The Hepatitis B Core (anti-HBc), IgM antibody test detects the presence of IgM antibodies against the hepatitis B core antigen (anti-HBc) in the blood. These antibodies are produced during the early stages of an acute hepatitis B infection and indicate that the infection is active.
This test is primarily used to diagnose a recent or active hepatitis B infection. It helps distinguish between acute and chronic infections and can be used to identify individuals who may be in the "window period" of infection, when other markers like hepatitis B surface antigen (HBsAg) may no longer be detectable.
A positive result for anti-HBc IgM typically indicates that the individual has an acute or recent hepatitis B infection. It means that the virus is actively replicating in the body. Further testing may be needed to assess the extent of the infection and determine the appropriate treatment.
A negative result suggests that the individual does not have an acute hepatitis B infection. However, it does not necessarily rule out a past infection, and additional tests (such as the Hepatitis B surface antigen or anti-HBs) may be recommended to assess the full history of exposure to the virus.
This test is recommended for individuals who show signs or symptoms of a hepatitis B infection, such as jaundice, fatigue, or abdominal pain. It is also useful for individuals who have been exposed to someone with hepatitis B, or those at risk, such as healthcare workers or people with multiple sexual partners.
No, the Hepatitis B Core (anti-HBc), IgM antibody test is specifically used to detect acute or recent infections. To assess if you've had a past infection, other tests such as the Hepatitis B (Core) Total Antibody or Hepatitis B surface antibodies are required.
No, individuals who have received the hepatitis B vaccine will not have hepatitis B core antibodies in their blood. The vaccine stimulates the immune system to produce antibodies against the hepatitis B surface antigen (anti-HBs), but it does not produce anti-HBc IgM antibodies.
If the test shows that you have an acute hepatitis B infection, your doctor will discuss the next steps, which may include additional tests, antiviral treatment, and monitoring of liver function. Early intervention can help prevent complications such as liver cirrhosis or liver cancer.
The Hepatitis B Core (anti-HBc), IgM antibody test specifically detects IgM antibodies produced during the early stages of an acute hepatitis B infection, indicating an active, recent infection. In contrast, the Hepatitis B (Core) Total Antibody test measures both IgM and IgG antibodies against the hepatitis B core antigen (anti-HBc), which can indicate past or ongoing exposure to the virus, even if the infection is not currently active.
No, the Hepatitis B Core (anti-HBc), IgM antibody test does not detect whether you are a chronic carrier of hepatitis B. Chronic carriers of hepatitis B typically test positive for hepatitis B surface antigen (HBsAg) but do not usually produce significant amounts of anti-HBc IgM antibodies. Chronic infection is generally monitored through tests like hepatitis B DNA or hepatitis B surface antigen levels.
Unlike the hepatitis B surface antibody (anti-HBs), which indicates immunity against hepatitis B, the core antibody (anti-HBc) signifies that the body has been exposed to the virus. It does not necessarily imply immunity.
Tata 1mg ensures accurate lab test results through certified laboratories that use advanced technology and adhere to stringent quality control measures. This commitment to high standards guarantees reliable results.

Hepatitis B Core (anti-HBc), IgM antibody test price for other cities

Price inBangaloreRs. 1139
Price inNew DelhiRs. 899
Price inKolkataRs. 989
Price inMumbaiRs. 989
Price inNoidaRs. 1050

How does home sample collection work?

Download the Tata 1mg app. Trusted healthcare, at your fingertips.

Book tests, track reports, and get AI-powered health insights.

or
Conducted by
Tata 1mg Labs
Accredited labs
Highly skilled Phlebos
Verified reports
Who will collect your samples?
Tata 1mg certified phlebotomists
Contains 1 test
Hepatitis B Core (anti-HBc), IgM antibody